Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-18054478 in persistent asthma
NCT00530166Phase 2Terminated
- Sponsor
- Johnson & Johnson
- Start
- Jul 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of JNJ-18054478 in asthma, sponsored by Johnson & Johnson. Started Jul 2007; status: terminated.
02
Drugs
JNJ-18054478
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00530166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530166.